Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT+-MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial
Lenalidomide;Rituximab;Temozolomide;Zanubrutinib;Methotrexate
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT+-MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial ### Output: Lenalidomide;Rituximab;Temozolomide;Zanubrutinib;Methotrexate